Product Description
| Tazobactam sodium and piperacillin sodium for inj. |
2.25g/4.5g |
1/10/50vial/box,600/1000vial/carton |
CP |
|
|
|
|
AI Product Description
*The following content is generated by AI and is for reference only.
Tazobactam sodium and piperacillin sodium for injection is a potent combination antibiotic therapy designed to treat serious bacterial infections caused by susceptible organisms. This formulation pairs piperacillin, an extended-spectrum penicillin antibiotic with broad activity against Gram-negative, Gram-positive, and anaerobic bacteria, with tazobactam, a beta-lactamase inhibitor. The primary function of tazobactam is to protect piperacillin from degradation by bacterial enzymes known as beta-lactamases, which many resistant strains produce to neutralize standard antibiotics. Consequently, this combination effectively treats infections that might otherwise be resistant to piperacillin alone.
Clinically, this injectable medication is indicated for a wide range of moderate to severe infections, including complicated intra-abdominal infections, skin and soft tissue infections, community-acquired pneumonia, nosocomial pneumonia, and urinary tract infections. It is also frequently utilized in the management of gynecological infections and septicemia. Due to its broad spectrum, it serves as a critical empirical therapy in hospital settings where multidrug-resistant pathogens are suspected.
However, several important precautions must be observed. Patients with a history of hypersensitivity to penicillins, cephalosporins, or other beta-lactam agents should not receive this drug due to the risk of severe allergic reactions, including anaphylaxis. Prior to administration, clinicians must assess renal function, as dosage adjustments are often required for patients with impaired kidney function since both components are primarily excreted renally. Additionally, prolonged use may lead to superinfections, such as fungal overgrowth or Clostridioides difficile-associated diarrhea. Careful monitoring of blood counts and liver function tests is recommended during long-term therapy. As with all parenteral antibiotics, aseptic technique is essential to prevent contamination. Healthcare providers should review potential drug interactions, particularly with probenecid or anticoagulants, before initiating treatment. This product is strictly for intravenous use and requires professional medical supervision to ensure safety and therapeutic efficacy.